Pentagastrin
A gastrin analogue.
CC(C)(C)OC(=O)NCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2–P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach
3CLpro Small molecule In silico |
in silico | 2.08 | Predicted to bind the SARS-CoV-2 3C-like protease. |
Sep/02/2020 |
|
In silico identification of drug candidates against COVID-19
3CLpro RdRpol |
in silico | 2.11 | Predicted to inhibit the SARS-CoV-2 3C-like protease. |
Oct/20/2020 |
